NASDAQ
Bellicum Pharmaceuticals, Inc. (BLCM) has a fcf yield of -116.25% as of Friday, May 29, 2026. This represents a 23.86% increase compared to its 12-month average of -152.69%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.